Cost-effectiveness of Cervical Cancer PreventionM. ESSELEN, KATHARINE MD, MBA; FELDMAN, SARAH MD, MPHClinical Obstetrics & Gynecology: March 2013 - Volume 56 - Issue 1 - p 55–64 doi: 10.1097/GRF.0b013e3182823797 Screening Tests for Cervical Cancer Abstract Author Information Cost-effectiveness analyses are an important tool for the evaluation and modification of many health care services. Given the variety of screening tests and treatments available for cervical cancer screening and prevention, the costs associated with these options and with their alternatives, and the differences in resources and settings in which these tests are applied worldwide, cost-effectiveness analyses evaluation can be very useful to help determine best practices. Brigham and Women’s Hospital, Boston, Massachusetts Supplemental Digital Content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website, http://www.clinicalobgyn.com. The authors declare that they have nothing to disclose. Correspondence: Sarah Feldman, MD, MPH, Brigham and Women’s Hospital, Boston, MA. E-mail: firstname.lastname@example.org © 2013 Lippincott Williams & Wilkins, Inc.